Sign In | Join Free | My himfr.com
Home > Ag Rapid Test Kit >

96.67% Sensitivity Ag Rapid Test Kit Lateral Flow Immunochromatography

    Buy cheap 96.67% Sensitivity Ag Rapid Test Kit Lateral Flow Immunochromatography from wholesalers
     
    Buy cheap 96.67% Sensitivity Ag Rapid Test Kit Lateral Flow Immunochromatography from wholesalers
    • Buy cheap 96.67% Sensitivity Ag Rapid Test Kit Lateral Flow Immunochromatography from wholesalers
    • Buy cheap 96.67% Sensitivity Ag Rapid Test Kit Lateral Flow Immunochromatography from wholesalers

    96.67% Sensitivity Ag Rapid Test Kit Lateral Flow Immunochromatography

    Ask Lasest Price
    Brand Name : ZOSBIO
    Model Number : 2019-NCoV Ag Rapid Test
    Certification : CE BfArm
    Price : To be negotiated
    Supply Ability : 10000 Kit/Kit per Day
    Delivery Time : To be negotiated
    • Product Details
    • Company Profile

    96.67% Sensitivity Ag Rapid Test Kit Lateral Flow Immunochromatography

    2019-NCoV Ag Rapid Test (Immunochromatography) Usage Manual For Self-Test Test Method


    Intended Use


    The kit is used for qualitative detection of ncov-Ag collected from human nasal swab samples in 2019.

    As a new weapon, ncov in 2019 is a new weapon β-Joe. It can cause viral pneumonia, and its main clinical manifestations are fever, fatigue and dry cough. A few patients suffer from nasal congestion, runny nose, sore throat, diarrhea and other symptoms. Critically ill patients usually develop dyspnea and/or hypoxemia after one week. In severe cases, it can rapidly develop into acute respiratory distress syndrome, septic shock, refractory metabolic acidosis and coagulation disorder.

    The 2019 ncovag strains in nasal swabs of suspicious patients were detected by lateral flow immunoassay. In the acute stage of infection, antigens are usually detected in nasal swab samples. A positive result indicates the existence of virus antigen, but the clinical correlation between the patient's medical history and other diagnostic information is also a necessary condition for determining the infection status. Positive results cannot rule out bacterial infection or co-infection with other viruses.

    This toolbox is used by laymen in non-laboratory environment (such as personal residence or some non-traditional places, such as offices, sports activities, airports, schools, etc.). The test results of this kit are for clinical reference only. It is suggested to make comprehensive analysis according to clinical manifestations and other laboratory tests.

    Principle of Detection


    The kit is an immunoassay kit based on the principle of double antibody sandwich technology. The 2019 ncov monoclonal antibody labeled with markers was sprayed on the binding pad as an indicator. In the test process, the 2019ncov-Ag in the sample combined with the labeled 2019ncov monoclonal antibody to form an Ag-AB complex. The complex migrated upward by capillary effect until it was captured by another 2019 ncov monoclonal antibody, forming a sandwich complex. If 2019 ncov-Ag exists in the sample, a red band will appear in the T area of the interpretation window. Otherwise, it will be a negative result. A control line (c) is used for program control. If the test program is executed correctly, it should always be displayed.


    Main Components


    The kit consists of a test card, a sample buffer and a swab.

    Test card: It consists of aluminum foil bag, desiccant, test strip and plastic card. The test strip consists of absorbent paper, nitrocellulose membrane, sample pad, adhesive pad and rubber sheet. T-line (test line) of nitrocellulose membrane was coated with 2019nCOVAb, C-line (quality control line) was coated with goat anti-mouse polyclonal Ab, and 2019nCOVAb was attached to the pad.

    Sample buffer: phosphate, sodium azide, etc.


    Storage Conditions and Validity



    Keep it at 2℃~30℃, and the validity period is tentatively set at 18 months.

    The validity period of aluminum foil bags is 1 hour.

    Production batch number: see the label for details.

    Expiry date: see the relevant contents of the label for details.


    Sample Requirements


    (1) nasal swab collection method: insert the sampling swab into the nostril, and insert the tip of the swab 2.5cm away from the edge of the nostril. Roll the swab along the mucosa in the nostril five times, and then repeat the process with the same swab (see Figure 1)

    Figure 1 Collection method for nasal swab


    (2) Sample treatment: the collected samples should be treated with the sample buffer provided by this box as soon as possible (if they can't be treated immediately, they should be stored in dry, sterilized and sealed containers), and stored at -70℃ within 2 hours (but avoid repeated freezing and thawing)

    Test Method


    Please read the instructions carefully before testing. Please return all reagents to room temperature before testing. The test should be carried out at room temperature.

    1. sample processing flow (see fig. 2)

    1. Insert the sampling swab into the sample buffer and rotate it close to the inner wall for about 10 times to make the sample dissolve in the solution as much as possible.

    2. Squeeze the tip of the swab along the inner wall of the tube to make the liquid flow into the tube as much as possible, and take out and discard the swab.

    3. Cover the dryer.


    Figure 2 Sample processing


    Figure 3 Detection procedure


    2. Test procedure (see Figure 3)

    1. take out the test card.

    2. Add 2 drops (about 80μ50) to extract the processed sample into the test card loading well, and then start the timer.

    3. Read the results after 15 minutes at room temperature. After 20 minutes, the result is invalid


    Interpretation of Test Results


    Test card description (figure 4):
    ① invalid result: the quality control line (line c) is invalid without response line, and should be tested again.
    ② Negative line result: the quality control line (line C) is red ribbon.
    ③ Positive results: The two red bands, test line (T line) and quality control line (C line) are all colored.


    Figure 4 Interpretation of test results


    Limitation of test method


    1. This product is used for qualitative detection, only for auxiliary diagnosis in vitro.
    2. This product is suitable for nasal swab samples. Results of other sample types may be inaccurate or invalid.
    3. Please make sure to add an appropriate number of samples for testing. Excessive or small sample size may lead to inaccurate results.
    4. The test results of this reagent are for clinical reference only, and should not be used as the only basis for clinical diagnosis and treatment. The final diagnosis can only be made after a comprehensive evaluation of all clinical and laboratory results.


    Product Performance Indicators


    1. detection limit: in this study, inactivated SARS-CoV-2 virus was used for culture, and the minimum detection limit of the kit was 6×102TCID50/mL.
    2. Use the company reference products for testing, and the results should meet the requirements of the company reference products.
    2.1 pass rate of positive control products: P1-P5 of positive control products of the company are all positive.
    2.2 pass rate of negative control products: N1-N10 of the company's negative control products are all negative.
    2.3 detection limit: the minimum detection limit reference products L1-L3 are detected, L1 is negative, L2 and L3 are positive.
    2.4 Reproducibility: The reference materials J1 and J2 were reused by the test company, and each test was positive 10 times.
    3. Cross-reaction: Add the following microorganisms and viruses to the samples at the specified concentration to evaluate their potential interference to the nCoVAg test items in 2019. The results showed that there was no cross reaction and interference from various microorganisms and viruses.


    SNMicroorganismsConcentrationCross reaction
    1Coronavirus (HKU1, OC43, NL63 and 229E)1.0×105TCID50/mLNo
    2H1N1 influenza (new type A H1N1 influenza virus (2009), seasonal H1N1 influenza virus), H3N2, H5N1, H7N91.0×105TCID50/mLNo
    3Influenza B (Yamagata strain, Victoria strain)2.5×105TCID50/mLNo
    4Respiratory syncytial virus2.8×105TCID50/mLNo
    5Group A, B, C of rhinovirus2.0×105TCID50/mLNo
    6Type 1, 2, 3, 4, 5, 7, 55 of adenovirus2.0×105TCID50/mLNo
    7Group A, B, C and D of enterovirus2.0×105TCID50/mLNo
    8EB virus2.0×105TCID50/mLNo
    9Measles virus2.0×105TCID50/mLNo
    10Human cytomegalovirus2.0×105TCID50/mLNo
    11Rotavirus2.0×105TCID50/mLNo
    12Norovirus2.0×105TCID50/mLNo
    13Mumps virus2.0×105TCID50/mLNo
    14Varicella-zoster virus2.0×105TCID50/mLNo
    15Mycoplasma pneumoniae1.0×106CFU/mLNo
    16Legionella pneumophila1.0×106CFU/mLNo
    17Haemophilus influenzae1.0×106CFU/mLNo
    18Streptococcus pyogenes (group A)1.0×106CFU/mLNo
    19Streptococcus pneumoniae1.0×106CFU/mLNo
    20Escherichia Coli1.0×106CFU/mLNo
    21Pseudomonas aeruginosa1.0×106CFU/mLNo
    22Neisseria meningitidis1.0×106CFU/mLNo
    23Candida albicans1.0×106CFU/mLNo
    24Staphylococcus aureus1.0×106CFU/mLNo

    4. Interference substances: In 2019 nCoV-Ag test project, the following concentrations of drugs were added to samples to evaluate their potential interference. The results showed that all kinds of drugs did not interfere with the detection results of reagents.


    Interfering substancesConcentrationInterfering substancesConcentration
    Mucoprotein1mg/mLRibavirin0.4mg/mL
    Whole Blood1%Fluticasone0.5mg/mL
    Oxymetazoline10mg/mLDexamethasone5 mg/mL
    Histamine hydrochloride10mg/mLTriamcinolone acetonide5mg /mL
    Tobramycin1mg/mLLevofloxacin0.2 mg/mL
    Oseltamivir1mg/mLAzithromycin0.1 mg/mL
    Zanamivir1mg/mLCeftriaxone0.4 mg/mL
    Arbidol0.5mg/mLMeropenem0.2 mg/mL

    5. Hook effect: In the high concentration range of 1.0, ×106TCID50/mL, 2019nCoV inactivated culture was not observed.
    6. Clinical research: Using RT-PCR detection reagent as contrast agent to evaluate nasal swab specimens. Choose 120 positive and 120 negative (RT-PCR detection), and use Zhongxiu reagent for detection. The research results are summarized as follows:


    Nasal swabRT-PCRSum
    PositiveNegative
    Positive1162118
    Negative4118122
    Sum120120240
    Sensitivity96.67%, (95%CI: 91.74%~98.70%)
    Specificity98.33%, (95%CI: 94.13%~99.54%)

    Precautions


    1. This product is only used for in vitro diagnosis.
    2. This product is disposable and cannot be recycled.
    3. Read the instructions carefully before operation, and carry out experimental operation in strict accordance with the reagent instructions.
    4. Avoid harsh environmental conditions (including 84 disinfectants, sodium hypochlorite, acid and alkali or acetaldehyde, and other high-concentration corrosive gases and dust, etc.). After the experiment, the laboratory should be disinfected.
    5. All samples and reagents used should be regarded as potentially infectious materials and treated according to local laws and regulations.
    6. The reagent should be used within the validity period indicated on the outer packaging. After taking it out of the aluminum foil bag, use the test card as soon as possible to prevent moisture.

    Logo interpretation


    Do not re-useStore at 2℃~30℃
    Consult instructions for useIn vitro diagnostic medical devic
    Batch codeUse-by date
    Keep dryKeep away from sunlight
    Authorized representative in the European CommunityManufacturer

    Basic Information




    ZHONGXIU SCIENCE AND TECHNOLOGY CO.,LTD

    Dingluan industrial zone ,Changyuan City,453400,P.R.CHINA

    Tel:+86-371-55016575

    Email:zosbio@zosbio.com

    SUNGO Europe B.V.

    Olympisch Stadion 24, 1076DE Amsterdam, Netherlands



    Company profile


    Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
    The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

    Quality 96.67% Sensitivity Ag Rapid Test Kit Lateral Flow Immunochromatography for sale
    Inquiry Cart 0
    Send your message to this supplier
     
    *From:
    *To: Henan Lantian Medical Supplies Co.,Ltd.
    *Subject:
    *Message:
    Characters Remaining: (0/3000)